Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder

OBJECTIVE: Many patients with major depressive disorder (MDD) suffer from residual symptoms without achieving remission. However, pharmacologic options for residual symptoms of MDD have been limited. This study aimed to investigate benefit of aripiprazole augmentation in the treatment of residual sy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Psychopharmacol Neurosci
Main Authors: Shin, Cheolmin, Pae, Chi-Un, Kwak, Kyung Phil, Jeon, Sang Won, Jeong, Hyun-Ghang, Kim, Jong-Woo, Lee, Youn Jung, Patkar, Ashwin A., Han, Changsu
Formato: Artigo
Idioma:Inglês
Publicado em: Korean College of Neuropsychopharmacology 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8077065/
https://ncbi.nlm.nih.gov/pubmed/33888653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2021.19.2.243
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados